Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss
postdoctoral position
6 views
Skip to first unread message
Tulin, Alexei V
May 31, 2018, 4:22:10 PM5/31/18
to dr...@magpie.bio.indiana.edu
Two Postdoctoral Positions
Applications are invited for postdoctoral positions. Both positions are planned for at least three years, with a possibility of renewal. The successful applicants will conduct research on epigenetic regulation of normal development and carcinogenesis. The primary research focus of the lab is on fundamentals of chromatin regulation and RNA fate during normal development and in carcinogenesis, as well as on translating the findings of fundamental biology for clinical applications in oncology. Projects in the lab cover the molecular mechanisms of chromatin remodeling and regulation of gene expression and employ in vitro assays as well as human cells, mouse and Drosophila model organisms.
Applicants should have a Ph.D. in molecular biology, molecular genetics, biochemistry, or a related field and no more than 3 years of postdoctoral research experience. Experience in genetics, confocal microscopy, protein purification, live-cell imaging, and genomics / proteomics would be helpful. We will start reviewing the application immediately until the position is filled. The top candidates will be invited for an interview and discussion of specific project.
To apply, please send or e-mail a letter of interest specifying your career goals, CV, and names of 3 referees to:
Alexei V. Tulin, PhD
Professor
Epigenetics Program
Department of Biomedical Sciences
School of Medicine and Health Sciences
University of North Dakota
501 North Columbia Road, Stop 9061
Grand Forks, ND 58202
E-mail: Alexei...@med.und.edu
http://med.und.edu/orgs/tulin-lab/index.cfm
http://med.und.edu/epigenetics
CONFIDENTIALITY NOTICE: This email communication may contain private, confidential, or legally privileged information intended for the sole use of the designated and/or duly authorized recipient(s). If you are not the intended recipient or have received this email in error, please notify the sender immediately by email and permanently delete all copies of this email including all attachments without reading them. If you are the intended recipient, secure the contents in a manner that conforms to all applicable state and/or federal requirements related to privacy and confidentiality of such information.
Applications are invited for postdoctoral positions. Both positions are planned for at least three years, with a possibility of renewal. The successful applicants will conduct research on epigenetic regulation of normal development and carcinogenesis. The primary research focus of the lab is on fundamentals of chromatin regulation and RNA fate during normal development and in carcinogenesis, as well as on translating the findings of fundamental biology for clinical applications in oncology. Projects in the lab cover the molecular mechanisms of chromatin remodeling and regulation of gene expression and employ in vitro assays as well as human cells, mouse and Drosophila model organisms.
Applicants should have a Ph.D. in molecular biology, molecular genetics, biochemistry, or a related field and no more than 3 years of postdoctoral research experience. Experience in genetics, confocal microscopy, protein purification, live-cell imaging, and genomics / proteomics would be helpful. We will start reviewing the application immediately until the position is filled. The top candidates will be invited for an interview and discussion of specific project.
To apply, please send or e-mail a letter of interest specifying your career goals, CV, and names of 3 referees to:
Alexei V. Tulin, PhD
Professor
Epigenetics Program
Department of Biomedical Sciences
School of Medicine and Health Sciences
University of North Dakota
501 North Columbia Road, Stop 9061
Grand Forks, ND 58202
E-mail: Alexei...@med.und.edu
http://med.und.edu/orgs/tulin-lab/index.cfm
http://med.und.edu/epigenetics
CONFIDENTIALITY NOTICE: This email communication may contain private, confidential, or legally privileged information intended for the sole use of the designated and/or duly authorized recipient(s). If you are not the intended recipient or have received this email in error, please notify the sender immediately by email and permanently delete all copies of this email including all attachments without reading them. If you are the intended recipient, secure the contents in a manner that conforms to all applicable state and/or federal requirements related to privacy and confidentiality of such information.
0 new messages